Jorge D Negron, BSN | |
Urb Brisa De Palmasola Calle & G 12, Aguas Buena, PR 00703 | |
(787) 477-3807 | |
Not Available |
Full Name | Jorge D Negron |
---|---|
Gender | Male |
Speciality | Registered Nurse - General Practice |
Location | Urb Brisa De Palmasola Calle & G 12, Aguas Buena, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720789027 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WG0000X | Registered Nurse - General Practice | 084568 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jorge D Negron, BSN Hc 03 Box 16083, Aguas Buena, PR 00703 Ph: (787) 477-3807 | Jorge D Negron, BSN Urb Brisa De Palmasola Calle & G 12, Aguas Buena, PR 00703 Ph: (787) 477-3807 |
News Archive
Plug the terms "alternative" and "cancer" into Google and the Internet search engine returns a list of 3.27 million - yes, million - sites with information both credible and questionable about nontraditional treatments for cancer. What's a cancer patient to make of such a vast array of options?
A team of scientists from the Federal State Budget Institution "Research Center for Obstetrics, Gynecology and Perinatology", Moscow Institute of Physics and Technology, the Emanuel Institute for Biochemical Physics, and the Talrose Institute for Energy Problems of Chemical Physics have developed an approach for a method of non-invasive testing for pregnant women with a serious and complex condition called preeclampsia.
A new study published in Clinical & Experimental Allergy reveals that there is no association between a restaurant worker's knowledge of food allergy and his or her confidence in being able to provide a safe meal to a food allergic customer.
Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has entered into a development and manufacturing agreement with ZZ Biotech, LLC. According to the agreement, Laureate will produce Activated Protein C variant under cGMP conditions. Terms of the manufacturing agreement were not disclosed.
› Verified 6 days ago